IP Verse

Dr. Falk Pharma GMBH vs Ellodi Pharmaceuticals LP

The detailed information for PTAB case with proceeding number IPR2025-00054 filed by Dr. Falk Pharma GMBH against Ellodi Pharmaceuticals LP on Oct 24, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-00054
Filing Date
Oct 24, 2024
Petitioner
Dr. Falk Pharma GMBH
Respondent
Ellodi Pharmaceuticals LP
Status
Trial Instituted
Respondent Application Number
16821464
Respondent Tech Center
1600
Respondent Patent Number
11246828
Institution Decision Date
Jun 3, 2025

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Patent Owner's Objections Pursuant to 37 CFR 42.64(b)(1)

Jun 17, 2025PAPERPATENT OWNER

Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314

Jun 3, 2025PAPERBOARD

Order: SCHEDULING ORDER

Jun 3, 2025PAPERBOARD

Petitioner's Supplmental Mandatory Notice

Dec 17, 2024PAPERPETITIONER

Notice: Notice filing date accorded

Dec 12, 2024PAPERBOARD

Notice : Mandatory Notice

Nov 14, 2024PAPERPATENT OWNER

Notice : Power of Attorney

Nov 14, 2024PAPERPATENT OWNER

U.S. Patent No. 11,246,828

Oct 24, 2024EXHIBITPETITIONER

U.S. Publication No. 20070111978

Oct 24, 2024EXHIBITPETITIONER

EP2482822B1

Oct 24, 2024EXHIBITPETITIONER

The Opposition Division of the European Patent Office decision revoking EP2

Oct 24, 2024EXHIBITPETITIONER

FDA Guidance for Industry - Orally Disintegrating Tablets

Oct 24, 2024EXHIBITPETITIONER

Notice of Publication of FDA Guidance for Industry on Orally Disintegrating

Oct 24, 2024EXHIBITPETITIONER

Notice of Publication of FDA Guidance for Industry on Orally Disintegrating

Oct 24, 2024EXHIBITPETITIONER

WO2000044351A1

Oct 24, 2024EXHIBITPETITIONER

Oral formulations of budesonide a novel treatment for inflammatory bowel

Oct 24, 2024EXHIBITPETITIONER

Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tab

Oct 24, 2024EXHIBITPETITIONER

Evaluation of oral budesonide in the treatment of active distal ulcerative

Oct 24, 2024EXHIBITPETITIONER

Eosinophilic gastroenteritis with severe protein-losing enteropathy Succes

Oct 24, 2024EXHIBITPETITIONER

Budesonide for the treatment of obstructive eosinophilic jejunitis

Oct 24, 2024EXHIBITPETITIONER

Topical viscous budesonide suspension for treatment of eosinophilic esophag

Oct 24, 2024EXHIBITPETITIONER

Oral Viscous Budesonide_ A potential new therapy for eosinophilic esophagit

Oct 24, 2024EXHIBITPETITIONER

The United States Pharmacopeia, USP 32

Oct 24, 2024EXHIBITPETITIONER

Intraoral Drug Delivery_ A Comparative Review

Oct 24, 2024EXHIBITPETITIONER

Orally fast disintegrating tablets developments, technologies, taste-mask

Oct 24, 2024EXHIBITPETITIONER

Mouth Dissolving Tablets I An overview of formulation technology, Scientia

Oct 24, 2024EXHIBITPETITIONER

U.S. Patent Publication No. 2005_0232988A1

Oct 24, 2024EXHIBITPETITIONER

Goodman And Gillman's

Oct 24, 2024EXHIBITPETITIONER

Budenofalk Brochure 2005

Oct 24, 2024EXHIBITPETITIONER

Budenofalk Advertisement 2007

Oct 24, 2024EXHIBITPETITIONER

Dr Falk Pharma Brochure (2008)

Oct 24, 2024EXHIBITPETITIONER

Curriculum Vitae of Dr. Alan F. Parr

Oct 24, 2024EXHIBITPETITIONER

Prosecution History excerpts 12896005

Oct 24, 2024EXHIBITPETITIONER

U.S. Patent No. 7,122,198 Singh

Oct 24, 2024EXHIBITPETITIONER

U.S. Patent No. 7,229,641

Oct 24, 2024EXHIBITPETITIONER

Prosecution history excerpts from U.S. Application No. 17_236,295

Oct 24, 2024EXHIBITPETITIONER

DisintegrationRevisedBulletin2008

Oct 24, 2024EXHIBITPETITIONER

Conway Solid Dosage Forms

Oct 24, 2024EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 5th Edition - Magnesium Stearate

Oct 24, 2024EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 5th Edition - Mannitol

Oct 24, 2024EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 5th Edition - Povidone

Oct 24, 2024EXHIBITPETITIONER

Handbook of Pharmaceutical Excipients 5th Edition - Sucralose

Oct 24, 2024EXHIBITPETITIONER

Handbook of Pharmaceutical Polyethylene

Oct 24, 2024EXHIBITPETITIONER

El-Arini 2002

Oct 24, 2024EXHIBITPETITIONER

File History Excerpts US10632069

Oct 24, 2024EXHIBITPETITIONER

File History Excerpts US11246828

Oct 24, 2024EXHIBITPETITIONER

Parr Declaration 828 patent

Oct 24, 2024EXHIBITPETITIONER

US Pat 10,632,069

Oct 24, 2024EXHIBITPETITIONER

Petition : as filed

Oct 24, 2024PAPERPETITIONER

Notice : Power of Attorney

Oct 24, 2024PAPERPETITIONER

[CORRECTED] Handbook of Pharmaceutical Excipients 5th Edition - Sucralose

Oct 24, 2024EXHIBITPETITIONER

Corrected Certificate of Service

Oct 24, 2024PAPERPETITIONER